HIF-1 Signaling in Drug Resistance to Chemotherapy

E-ISSN： 1875-533x|21|26|3021-3028

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.26, 2014-09, pp. : 3021-3028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIF-1 as a Target for Cancer Chemotherapy, Chemosensitization and Chemoprevention

Current Molecular Pharmacology, Vol. 4, Iss. 1, 2011-01 ,pp. : 62-77

Bentham Science Publishers

Access to resources Recommend Favorite

The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 275-286

Bentham Science Publishers

Access to resources Recommend Favorite

Growth Factor Signaling and Resistance to Cancer Chemotherapy

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 13, 2004-09 ,pp. : 1345-1354

Bentham Science Publishers

Access to resources Recommend Favorite

A Prevention Strategy for Circumventing Drug Resistance in Cancer Chemotherapy

Current Pharmaceutical Design, Vol. 7, Iss. 16, 2001-11 ,pp. : 1595-1614

Bentham Science Publishers

Access to resources Recommend Favorite

HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery

Current Pharmaceutical Design, Vol. 15, Iss. 33, 2009-11 ,pp. : 3839-3843

Bentham Science Publishers

Access to resources Recommend Favorite